Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G

Ganieva Z.B., Fayzieva Z.T.

Abstract: The authors studied the embryotoxic and teratogenic effects of the capsule Uroconite-0.2 g. The results of the study proved that the studied capsule - Uroconite-0.2 g in doses of 100 and 500 mg/kg does not adversely affect the development of the fetus in experimental animals. Therefore, the capsule Uroconite-0.2 g does not involve embryotoxic and teratogenic effects.

Keywords: Uroconite-02 g, embryotoxicity, teratogenicity, fetus, pathology and anomalies

How to Cite?: Ganieva Z.B., Fayzieva Z.T., "Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G", Volume 9 Issue 5, May 2020, International Journal of Science and Research (IJSR), Pages: 1149-1151, https://www.ijsr.net/getabstract.php?paperid=SR20419122222, DOI: https://dx.doi.org/10.21275/SR20419122222